SCHEMBL18565388

SCHEMBL18565388

Cn1c2ccccc2c2cc(-c3ccc4c(c3)[Si](C)(C)c3ccccc3-4)ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.44
KDM4E B2RXH2 4/20 0.43
HSD17B10 Q99714 4/20 0.43
MAPT P10636 3/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
ALDH1A1 P00352 3/20 0.43
HPGD P15428 3/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
HTT P42858 1/20 0.43
NPY5R Q15761 1/20 0.39
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
PABPC1 P11940 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18565384 0.92 RXRA (0.47) GPR3KDM4EHSD17B10MAPTL3MBTL1
SCHEMBL13508041 0.89 GPR3 (0.42) GPR3KDM4EHSD17B10MAPTL3MBTL1
SCHEMBL18565423 0.88 LMNA (0.35) GPR3KDM4EHSD17B10MAPTL3MBTL1
SCHEMBL20276906 0.85 L3MBTL1 (0.46) KDM4EMAPTL3MBTL1ALDH1A1KMT2A
SCHEMBL13506986 0.85 GPR3 (0.41) GPR3KDM4EHSD17B10MAPTL3MBTL1
SCHEMBL18565461 0.85 KMT2A (0.33) GPR3KDM4EHSD17B10MAPTL3MBTL1
SCHEMBL13507040 0.84 L3MBTL1 (0.36) GPR3KDM4EHSD17B10MAPTL3MBTL1
SCHEMBL13507380 0.84 GPR3 (0.42) GPR3KDM4EHSD17B10MAPTL3MBTL1
SCHEMBL18565381 0.84 ALKBH5 (0.44) GPR3KDM4EHSD17B10MAPTL3MBTL1
SCHEMBL18565389 0.84 GPR3 (0.39) GPR3KDM4EHSD17B10MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-14 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device EED, BMI1, CD99 GPR3 3915/4885KDM4E 225/4885HSD17B10 4257/4885
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 GPR3 3915/4885KDM4E 225/4885HSD17B10 4257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.